Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.34 USD | +0.29% | -5.11% | +12.32% |
05-13 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
05-10 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |